Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Idaigaoka 1-1, Hasama-machi, Yufu-shi, Oita 879-5593, Japan.
J Clin Endocrinol Metab. 2011 Dec;96(12):E1944-52. doi: 10.1210/jc.2011-1503. Epub 2011 Sep 14.
During the development of endometriotic lesions, excess fibrosis may lead to scarring and to the alterations of tissue function that are the characteristic features of this disease. Enhanced extracellular matrix contractility of endometriotic stromal cells (ECSC) mediated by the mevalonate-Ras homology (Rho)/Rho-associated coiled-coil-forming protein kinase (ROCK) pathway has been shown to contribute to the pathogenesis of endometriosis.
To assess the use of fasudil, a selective ROCK inhibitor, for the medical treatment of endometriosis-associated fibrosis, the effects of this agent on the cell proliferation, apoptosis, cell cycle, morphology, cell density, and contractility of ECSC were investigated. The effects of fasudil on the expression of contractility-related, apoptosis-related, and cell cycle-related molecules in ECSC were also evaluated.
Fasudil significantly inhibited the proliferation and contractility of ECSC and induced the cell cycle arrest in the G2/M phase and apoptosis of these cells. Morphological observation revealed the suppression of ECSC attachment to collagen fibers and decrease of cell density by fasudil. The expression of α-smooth muscle actin, RhoA, ROCK-I, and ROCK-II proteins was inhibited by fasudil administration. The expression of the antiapoptotic factors, Bcl-2 and Bcl-X(L), in two-dimensional cultured ECSC were down-regulated by the addition of fasudil, whereas, the expression of p16(INK4a) and p21(Waf1/Cip1) was up-regulated by the addition of fasudil.
The present findings suggest that fasudil is a promising agent for the treatment of endometriosis. The inhibition of cell proliferation, contractility, and myofibroblastic differentiation, the attenuation of attachment to collagen fibers, the decrease of cell density, and the induction of cell cycle arrest and apoptosis of ECSC are involved in the active mechanisms of fasudil.
在子宫内膜异位症病变的发展过程中,过度纤维化可能导致瘢痕形成,并改变组织功能,这是这种疾病的特征。已经表明,甲羟戊酸-Ras 同源(Rho)/Rho 相关卷曲螺旋形成蛋白激酶(ROCK)通路介导的子宫内膜间质细胞(ECSC)的细胞外基质收缩增强有助于子宫内膜异位症的发病机制。
为了评估选择性 ROCK 抑制剂法舒地尔在子宫内膜异位症相关纤维化的治疗中的应用,研究了该药物对 ECSC 细胞增殖、凋亡、细胞周期、形态、细胞密度和收缩性的影响。还评估了法舒地尔对 ECSC 中与收缩性、凋亡和细胞周期相关的分子表达的影响。
法舒地尔显著抑制 ECSC 的增殖和收缩性,并诱导这些细胞的细胞周期停滞在 G2/M 期和凋亡。形态学观察显示法舒地尔抑制 ECSC 附着在胶原纤维上并降低细胞密度。α-平滑肌肌动蛋白、RhoA、ROCK-I 和 ROCK-II 蛋白的表达被法舒地尔抑制。二维培养的 ECSC 中抗凋亡因子 Bcl-2 和 Bcl-X(L)的表达被法舒地尔下调,而 p16(INK4a)和 p21(Waf1/Cip1)的表达被法舒地尔上调。
本研究结果表明,法舒地尔是治疗子宫内膜异位症的一种有前途的药物。抑制细胞增殖、收缩性和肌成纤维分化、减弱对胶原纤维的附着、降低细胞密度以及诱导细胞周期停滞和凋亡是法舒地尔的积极作用机制。